Vitreous glutamate concentration and axon loss in monkeys with experimental glaucoma

Archives of Ophthalmology

Volumn 123, Issue 1, 2005, Pages 64-70

  Wamsley, Sonja ^a   Gabelt, B'Ann T ^a   Dahl, David B ^a   Case, Gary L ^b   Sherwood, Robert W ^c   May, Christian A ^d   Hernandez, M Rosario ^e   Kaufman, Paul L ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c Department of Obstetrics Gynecology   (United States)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXCITOTOXIN; GLUTAMIC ACID;

AMINO ACID ANALYSIS; ARTICLE; CELL DEATH; CORRELATION ANALYSIS; GLAUCOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; INTRAOCULAR PRESSURE; MOLECULAR WEIGHT; MONKEY; NERVE FIBER DEGENERATION; NONHUMAN; OPTIC NERVE LESION; PRIORITY JOURNAL; RETINA GANGLION CELL; VITREOUS BODY;

ANIMALS; AXONS; CELL COUNT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FEMALE; GLAUCOMA; GLUTAMIC ACID; INTRAOCULAR PRESSURE; LASER SURGERY; MACACA FASCICULARIS; MACACA MULATTA; MALE; OPTIC NERVE; OPTIC NERVE DISEASES; TRABECULAR MESHWORK; VITREOUS BODY;

EID: 12144262037     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.123.1.64     Document Type: Article

References (31)

1. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988;1:623-634.
2. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994;330:613-622.
3. Lucas DR, Newhouse JP. The toxic effect of sodium L-glutamate on the inner layers of the retina. Arch Ophthalmol. 1957;58:193-201.
4. Vorwerk CK, Lipton SA, Zurakowski D, et al. Chronic low dose glutamate is toxic to retinal ganglion cells: toxicity blocked by memantine. Invest Ophthalmol Vis Sci. 1996;37:1618-1624.
5. Brooks DE, Garcia GA, Dreyer EB, Zurakowski D, Franco-Bourland RE. Vitreous body glutamate concentration in dogs with glaucoma. Am J Vet Res. 1997; 58:864-867.
6. Dreyer EB. Amino acid abnormalities in the vitreous of the buphthalmic rabbit. Vet Comp Ophthalmol. 1997;7:192-195.
7. Yoles E, Schwartz M. Elevation of introacular glutamate levels in rats with partial lesion of the optic nerve. Arch Ophthalmol. 1998;116:906-910.
8. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol. 1996;114:299-305.
9. Honkanen RA, Baruah S, Zimmerman MB, et al. Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy. Arch Ophthalmol. 2003; 121:183-188.
10. Carter-Dawson L, Crawford ML, Harwerth RS, et al. Vitreal glutamate concentration in monkeys with experimental glaucoma. Invest Ophthalmol Vis Sci. 2002; 43:2633-2637.
11. Lagreze WA, Knorle R, Bach M, Feuerstein TJ. Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Invest Ophthalmol Vis Sci. 1998; 39:1063-1066.
12. Levkovitch-Verbin H, Martin KRG, Quigley HA, Baumrind LA, Pease ME, Valenta D. Measurement of amino acid levels in the vitreous humor of rats after chronic intraocular pressure elevation or optic nerve transection. J Glaucoma. 2002; 11:396-405.
13. Gaasterland D, Kupfer C. Experimental glaucoma in the rhesus monkey. Invest Ophthalmol. 1974;13:455-457.
14. Quigley HA, Hohman RM. Laser energy levels for trabecular meshwork damage in the primate eye. Invest Ophthalmol Vis Sci. 1983;24:1305-1307.
15. B'ar'any EH. Simultaneous measurements of changing intraocular pressure and outflow facility in the vervet monkey by constant pressure infusion. Invest Ophthalmol. 1964;31:135-143.
16. Kaufman PL, Davis GE. "Minified" Goldmann applanating prism for tonometry in monkeys and humans. Arch Ophthalmol. 1980;98:542-546.
17. Ito S, Karnovsky MJ. Formaldehyde-glutaraldehyde fixatives containing trinitro compounds. J Cell Biol. 1968;39(suppl):168A-169A. Abstract 418.
18. Bidlingmeyer BA, Cohen SA, Tarvin TL. Rapid analysis of amino acids using precolumn derivatization. J Chromatogr. 1984;336:93-104.
19. Quigley HA, Addicks EM, Green WR. Optic nerve damage in human glaucoma, III: quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol. 1982;100:135-146.
20. Pena JD, Agapova O, Gabelt BT, et al. Increased elastin expression in astrocytes of the lamina cribrosa in response to elevated intraocular pressure. Invest Ophthalmol Vis Sci. 2001;42:2303-2314.
21. Grossie VB, Yick J, Alpeter M, Welbourne TC, Ota DM. Glutamine stability in biological tissues evaluated by fluorometric analysis. Clin Chem. 1993;39:1059-1063.
22. Heickelf AG, Bellezza AJ, Thompson HW, Burgoyne CF. Optic disc surface compliance testing using confocal scanning laser tomography in the normal monkey eye. J Glaucoma. 2001;10:369-382.
23. Asensio Sánchez VM, Corral Azor A, Aquirre Aragón B, De Paz Garcia M. Amino acid concentrations in the vitreous body in control subjects. Arch Soc Esp Oftalmol. 2002;77:611-616.
24. Vorwerk CK, Gorla MSR, Dreyer EB. An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy. Surv Ophthalmol. 1999;43:S142-S150.
25. Sucher NJ, Aizenman E, Lipton SA. N-methyl-d-aspartate antagonists prevent kainate neurotoxicity in rat retinal ganglion cells in vitro. J Neurosci. 1991; 11:966-971.
26. Siliprandi R, Canella R, Carmignoto G, et al. N-methyl-d-aspartate- induced neurotoxicity in the adult rat retina. Vis Neurosci. 1992;8:567-573.
27. Sucher NJ, Lei SZ, Lipton SA. Calcium channel antagonists attenuate NMDA receptor-mediated neurotoxicity of retinal ganglion cells in culture. Brain Res. 1991; 551:297-302.
28. WoldeMussie E, Yoles E, Schwartz M, Ruiz G, Wheeler LA. Neuroprotective effect of memantine in different retinal injury models in rats. J Glaucoma. 2002;11: 474-480.
29. Carter-Dawson L, Shen F, Harwerth RS, et al. Glutamine immunoreactivity in Müller cells of monkey eyes with experimental glaucoma. Exp Eye Res. 1998;66:537-545.
30. Schori H, Kipnis J, Yoles E, et al. Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc Natl Acad Sci U S A. 2001;98:3398-3403.
31. Martin KR, Levkovitch-Verbin H, Valenta D, et al. Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat. Invest Ophthalmol Vis Sci. 2002;43:2236-2243.